LimFlow provides health economics and reimbursement resources to support patient access to the TADV procedure with the LimFlow System.
Reimbursement Guide and Resources
The purpose of this information is to provide U.S. Commercial and PROMISE III Clinical Study Sites with information to support reimbursement efforts for TADV procedures with the LimFlow System.
Official Approval Letter from CMS
Available here on CMS’ List of Category B IDE Studies Approved for Coverage of the Category B device and related services, and routine services.
"*" indicates required fields